This episode explores the differences between research peptides and pharmaceutical peptides, highlighting that although they are chemically identical, pharmaceutical versions tend to be more expensive due to regulatory factors. There's an emphasis on personal preference regarding trust in the FDA, with a preference for research peptides from specialized labs that focus solely on peptide production.

Potential dangers of using GLP-1 drugs, such as Semaglutide, are also discussed, particularly the risk of muscle loss, which can lead to metabolic issues and weakened physical function. The importance of understanding metabolic chemistry and prioritizing fat loss over weight loss is stressed, with a recommendation to focus on macronutrients rather than calories for better health outcomes.

Highlights of the Podcast



00:04 - Difference Between Research and Pharmaceutical Peptides

02:35 - Peptide Manufacturing Preferences

04:42 - Dangers of Muscle Loss with GLP-1 Drugs (Semaglutide)

09:02 - Glucagon and Diabetes Management

11:47 - Calories vs. Macros